Mouse Anti-COMMD10 Recombinant Antibody (CBWJC-2945) (V2LY-1206-LY723)

Yang, M., Wu, X., Li, L., Li, S., Li, N., Mao, M., ... & Guan, J. (2021). COMMD10 inhibits tumor progression and induces apoptosis by blocking NF‐κB signal and values up BCLC staging in predicting overall survival in hepatocellular carcinoma. Clinical and translational medicine, 11(5), e403.

Cohen, K., Mouhadeb, O., Shlomo, S. B., Langer, M., Neumann, A., Erez, N., ... & Varol, C. (2021). COMMD10 is critical for Kupffer cell survival and controls Ly6Chi monocyte differentiation and inflammation in the injured liver. Cell reports, 37(7), 110026.

Fan, Y., Zhang, L., Sun, Y., Yang, M., Wang, X., Wu, X., ... & Guan, J. (2020). Expression profile and bioinformatics analysis of COMMD10 in BALB/C mice and human. Cancer gene therapy, 27(3), 216-225.

Rasulov, S. (2020). COMMD10 in epithelial sodium channel (ENaC) trafficking (Doctoral dissertation, University of Otago).

Yang, M., Wu, X., Li, L., Li, S., Pan, S., Du, R., ... & Guan, J. (2019). Inflammation-Related Biomarker COMMD10 Values Up BCLC Staging in Individualized Prediction of Overall Survival in Hepatocellular Carcinoma.

Ware, A. W., Cheung, T. T., Rasulov, S., Burstein, E., & McDonald, F. J. (2018). Epithelial Na+ channel: reciprocal control by COMMD10 and Nedd4-2. Frontiers in Physiology, 9, 793.

Yang, S. S., Li, X. M., Yang, M., Ren, X. L., Hu, J. L., Zhu, X. H., ... & Liang, L. (2017). FMNL2 destabilises COMMD10 to activate NF-κB pathway in invasion and metastasis of colorectal cancer. British journal of cancer, 117(8), 1164-1175.

Ware, A. W. (2017). COMMD10 regulates protein trafficking (Doctoral dissertation, University of Otago).

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols